WELLS FARGO & COMPANY/MN - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2017$4,0000.0%1,0000.0%0.00%
Q4 2016$4,000
-99.9%
1,000
-99.9%
0.00%
-100.0%
Q3 2013$4,416,000
+27.8%
1,229,000
-1.4%
0.00%0.0%
Q2 2013$3,455,0001,247,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2016
NameSharesValueWeighting ↓
Amici Capital, LLC 8,000,000$35,720,0001.61%
Baker Brothers Advisors 22,898,000$102,104,0001.04%
CITIGROUP INC 6,176,000$27,560,0000.02%
SG Americas Securities, LLC 10,000$4,465,0000.02%
SSI INVESTMENT MANAGEMENT LLC 37,000$165,0000.02%
GEODE CAPITAL MANAGEMENT, LLC 1,000,000$4,462,0000.00%
Allianz Asset Management GmbH 300,000$1,340,0000.00%
UBS Group AG 22,000$98,0000.00%
ROYAL BANK OF CANADA 2,000$8,0000.00%
MORGAN STANLEY 11,000$49,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders